Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • INVESTMENT ADVISERS—SEC, CFTC approve extension of Form PF compliance deadline to Oct. 1, 2026
    • BLOCKCHAIN—Coinbase urges DOJ to support federal preemption of state laws, shield crypto from states’ oversight
    • EXCHANGES AND MARKET REGULATION—AIMA petitions the SEC for rulemaking to amend Rule 105 of Regulation M
    • FRAUD AND MANIPULATION—2d. Cir.: Sale of Archegos positions before collapse was not insider trading
    • FRAUD AND MANIPULATION—S.D.N.Y.: $6.9M consent order effected in ‘Silver Lease’ matter
    • FRAUD AND MANIPULATION—S.D.N.Y.: Former Voyager CEO to pay $750,000 in CFTC fraud case
    • SECURITIES OFFERINGS—Commissioner policy statement seeks to clarify application of FAA
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Securities Regulation Daily Wrap Up, EXCHANGES AND MARKET REGULATION—AIMA petitions the SEC for rulemaking to amend Rule 105 of Regulation M, (Sep 17, 2025)

    By R. Jason Howard, J.D.

    It has been almost 20 years since the rule was updated, the group notes.

    The Alternative Investment Management Association (AIMA) has petitioned the SEC for a rulemaking to amend Rule 105 of SEC Regulation M or, alternatively, requests that the SEC pr ...

    By R. Jason Howard, J.D.

    It has been almost 20 years since the rule was updated, the group notes.

    The Alternative Investment Management Association (AIMA) has petitioned the SEC for a rulemaking to amend Rule 105 of SEC Regulation M or, alternatively, requests that the SEC provide relief or interpretive guidance through an Exemptive Order or no-action relief to address the need to modernize Regulation M to reflect current market dynamics.

    The AIMA petition explains that “Rule 105 governs short selling in connection with public offerings and concerns short sales that are effected prior to the pricing of an offering.” The Rule is specifically designed to “safeguard the integrity of the capital raising process by ensuring investors in a follow-on or secondary registered offering of equity securities do not artificially depress market prices through short selling in advance of the offering.”

    AIMA notes that it fully endorses the stated goal of Rule 105 to “foster secondary and follow-on offering prices that are determined by independent market dynamics and not by potentially manipulative activity,” but cautions that because the rule has not been updated in almost two decades, it does not take into account the market developments concerning how equity securities are offered to investors, “particularly the dramatic growth of overnight offerings.”

    According to AIMA, Rule 105, “unnecessarily limits investor participation in equity offerings, in effect penalizing short selling done without any knowledge of any future offering, thereby stifling capital formation and hindering market efficiency, to the detriment of issuers attempting to raise capital.” In addition, AIMA states that the “provisions and interpretations also present significant implementation challenges to investment firms as they both manage risk and seek to participate in offerings, potentially impairing markets and the broader economy.”

    AIMA is seeking an opportunity to work with the SEC to modernize Regulation M to reflect current market dynamics, while ensuring that the rule work for overnight offerings, “which now constitute the vast majority of all follow-on and secondary offerings.”

    RegulatoryActivity: BrokerDealers ExchangesMarketRegulation FedTracker Securities GCNNews InvestmentCompanies InvestorEducation

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use